Udit Batra named CEO, Merck KGaA's life science division
This article was originally published in Scrip
Executive Summary
EMD Millipore, the life sciences division of Merck KGaA, has named Dr Udit Batra president and chief executive officer – effective 15 May 2014. Dr Batra will lead EMD Millipore's strategic direction and operation from its US headquarters in greater Boston, Massachusetts, and will focus on the globalization and growth of the company. He joins EMD Millipore from Merck KGaA's consumer health division. Prior to his time at Merck KGaA, Dr Batra was head of global public health and market access at Novartis Vaccines and Diagnostics.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.